Injective price prediction: $4.85 support in focus as INJ slides 7.28%

Traders Union
All News
Crypto
Injective slides 7.28% today to $5.12

Highlights

Injective faces strong bearish momentum as it trades below short- and medium-term moving averages despite remaining above the long-term trend line.
Momentum and sentiment indicators collectively signal seller dominance and potential downside exhaustion, with high intraday volatility confirming strong downside pressure.
INJ is expected to trade within a $4.85–$5.39 range, with a high probability of further declines unless support at $4.85 holds.

Bearish momentum builds with support above long-term average

On the technical front, INJ trades below the MA-20 at $5.28 and MA-50 at $5.44, while its daily chart remains above the long-term MA-200 at $4.19. The Ichimoku Kijun line at $5.35 serves as immediate resistance. Key momentum indicators show MACD on Sell and ADX at Neutral. The Relative Strength Index is at 35.33 (Sell signal), and CCI is Oversold. Stoch RSI remains Neutral, with BBP confirming seller dominance intraday. The Awesome Oscillator points to further downside, with price action settling near today's low and high volatility confirming strong selling pressure.

Downside risk dominates as price stuck in narrow band

Over the short term, INJ is likely to remain within the $4.85 to $5.39 range, tracking typical volatility around current levels. The probability of further downside is considered very high, while a move higher is deemed very unlikely. A sideways scenario between these support and resistance bands is the baseline expectation. A bullish breakout would require a sustained move above the $5.35 Kijun resistance, whereas a failure of support below $4.85 could trigger further selling momentum.

Viktoras Karapetjanc, expert at Traders Union, sees strong selling pressure weighing on Injective, with price holding below key short- and medium-term averages but still above the longer-term trend. Momentum indicators remain negative, and absence of fresh news leaves sentiment unbalanced and directionless. The analyst believes downside risks are elevated if $4.85 fails, with only a decisive move above $5.35 changing the picture. "I remain cautiously optimistic and will watch for a reversal signal above $5.35 before considering a bullish stance on INJ."

Earlier, analysts noted that Injective was experiencing short-term bearish momentum despite ongoing developments and longer-term support. The latest technical deterioration suggests that downside risk remains elevated, making a confirmed break below the $4.85 level a critical signal for accelerating losses.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.